KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Pension (2016 - 2025)

Historic Pension for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to $6.5 million.

  • NovoCure's Pension fell 1744.8% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 1744.8%. This contributed to the annual value of $6.9 million for FY2024, which is 1596.03% down from last year.
  • According to the latest figures from Q3 2025, NovoCure's Pension is $6.5 million, which was down 1744.8% from $6.3 million recorded in Q2 2025.
  • In the past 5 years, NovoCure's Pension registered a high of $8.3 million during Q4 2023, and its lowest value of $2.0 million during Q3 2021.
  • Over the past 5 years, NovoCure's median Pension value was $5.1 million (recorded in 2023), while the average stood at $5.1 million.
  • Its Pension has fluctuated over the past 5 years, first tumbled by 5556.77% in 2021, then skyrocketed by 10128.02% in 2022.
  • NovoCure's Pension (Quarter) stood at $4.5 million in 2021, then dropped by 3.06% to $4.4 million in 2022, then soared by 87.51% to $8.3 million in 2023, then decreased by 15.96% to $6.9 million in 2024, then fell by 6.12% to $6.5 million in 2025.
  • Its Pension was $6.5 million in Q3 2025, compared to $6.3 million in Q2 2025 and $5.8 million in Q1 2025.